Use of anti-TNF drug levels to optimise patient management.
about
Utilisation of anti-TNF levels in a UK tertiary IBD centre.Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease.Editorial: therapeutic de-escalation of anti-tumour necrosis factor therapy - is less enough?Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy.The old versus the new: which do you keep in postoperative Crohn's disease?Improving IBD Care: A Personalized Approach to Management.
P2860
Q38608944-F9C13347-1AC0-41AE-AC30-28E5F874D3C8Q38620415-4DB5A6F5-DCB1-4C8E-82E1-5FF7EB93B6F5Q47258474-FCF15F44-E4C2-4EBD-8F0F-C29507F43BF9Q48230305-5400305D-0DFB-4916-97CF-EAE2F462536AQ48288875-FFD4B172-143E-4768-BA29-5CE2C88F44C6Q48334518-A4F15544-0B64-49C7-95DF-53935C75A1A7Q50759070-87ACDFBD-C610-47E4-BFF4-B2E4CB1A7149Q54028296-87B7417B-5B85-40E6-B0BF-D01309C17341Q55175032-D2AF71B8-6D36-4AC9-8FFB-FC20283577B6Q55512056-B99C6B9D-D96F-4F63-870D-7AE359904352
P2860
Use of anti-TNF drug levels to optimise patient management.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of anti-TNF drug levels to optimise patient management.
@en
type
label
Use of anti-TNF drug levels to optimise patient management.
@en
prefLabel
Use of anti-TNF drug levels to optimise patient management.
@en
P2860
P1476
Use of anti-TNF drug levels to optimise patient management.
@en
P2093
Adam S Cheifetz
Konstantinos Papamichael
P2860
P304
P356
10.1136/FLGASTRO-2016-100685
P577
2016-02-26T00:00:00Z